Cleveland BioLabs
-$0.50 (-8.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell CBLI and other stocks, options, and ETFs commission-free!
About CBLI
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome.
CEO
Christopher Zosh
Employees
6
Headquarters
Buffalo, New York
Founded
2003
CBLI Key Statistics
Market Cap
82.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
103.23K
High Today
$5.85
Low Today
$5.32
Open Price
$5.80
Volume
87.76K
52 Week High
$10.97
52 Week Low
$1.53
CBLI Earnings
-$0.80
-$0.53
-$0.27
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market